One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry

Poster published in 2018 by Bente Glintborg, Jensen Dorte Vendelbo, I. J. Sørensen, E. Omerovic, F. Mehnert, N. Manilo, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Anne Gitte Loft, Oliver Hendricks, S. Chrysidis, B. L. Andersen, Johnny Lillelund Raun, Hanne Merete Lindegaard and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload